We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

88 hedge funds and large institutions have $223M invested in Applied Genetic Technologies Corporation in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 4

158% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 12

84% more capital invested

Capital invested by funds: $121M → $223M (+$102M)

47% more funds holding

Funds holding: 6088 (+28)

Holders
88
Holders Change
+28
Holders Change %
+46.67%
% of All Funds
2.31%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
32
Increased
31
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change

AGTC Hedge Fund Activity: Q4 2015 in Review

88 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2015, worth a combined $223M — up 84% from $121M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new AGTC positions and 4 closed out — a net gain of 28 holders — while 31 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $6.28M. The largest seller was Visium Asset Management, cutting an estimated $7.25M.

  • 88 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2015, up from 60 in Q3 2015.
  • Funds reported $223M of Applied Genetic Technologies Corporation stock for Q4 2015, up 84% quarter-over-quarter.
  • 32 funds opened new Applied Genetic Technologies Corporation positions in Q4 2015 and 4 closed out, a net change of +28 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2015 was Fidelity Investments, an estimated $6.28M added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2015 was Visium Asset Management, an estimated $7.25M sold.

Based on aggregated 13F filings for Q4 2015.